Legal Opinion
In re ACTOS Antitrust Litigation
District Court, S.D. New York
Decided September 30, 2019No. 1:13-cv-09244Unknown
1Opinion
UNITED STATES DISTRICT COURT ELECTRONICALLY FILED SOUTHERN DISTRICT OF NEW YORK DOC#: DATE FILED: 09/30/2019 No. 13-CV-9244 (RA) IN RE ACTOS END-PAYOR ANTITRUST LITIGATION OPINION AND ORDER RONNIE ABRAMS, United States District Judge: This case concerns whether Defendants Takeda Pharmaceutical Company Limited, Takeda America Holdings, Inc., Takeda Pharmaceuticals U.S.A., Inc., and Takeda Development Center Americas, Inc. (collectively “Takeda”) are liable to the indirect purchasers of Takeda’s diabetes medication called ACTOS (“End-Payor Plaintiffs” or “EPPs”), for unlawfully inflating that…
2Cases cited30 opinions
- Ashcroft v. IqbalSupreme Court of the United States · 2009
- Bell Atlantic Corp. v. TwomblySupreme Court of the United States · 2007
- Brunswick Corp. v. Pueblo Bowl-O-Mat, Inc.Supreme Court of the United States · 1977
- Eastern Railroad Presidents Conference v. Noerr Motor Freight, Inc.Supreme Court of the United States · 1961
- United Mine Workers v. PenningtonSupreme Court of the United States · 1965
25 more not listed; retrieve them via the Exa API.